My Tiny Feed

nbcnews.com

GLP-1 Drugs Show Promise in Treating Alcohol Addiction

A new study suggests that the diabetes drugs Ozempic and Wegovy may also help reduce alcohol consumption in individuals with alcohol use disorder, offering a potential new treatment avenue.

Read original article in English

English

United States

HealthLifestyleTreatmentAddictionAlcoholDiabetesDrug

National Institute On Alcohol Abuse And AlcoholismNiuvanniemi HospitalVirginia Tech’s Fralin Biomedical Research InstituteUniversity Of Southern California Institute For Addiction Science

Alex DifeliceantonioMarkku LähteenvuoChristian Hendershot

Why is further research on GLP-1 drugs for alcohol addiction considered crucial?: Current treatments for alcohol use disorder are limited, highlighting the need for additional effective medications. GLP-1 drugs offer a potential new avenue, although further research is needed.
What are some of the proposed mechanisms by which GLP-1 drugs might help reduce alcohol consumption?: While the mechanism isn't fully understood, theories suggest GLP-1 drugs might reduce cravings by inducing satiation or decreasing the rewarding effects of alcohol, potentially impacting sugar cravings as well.
What potential safety concerns regarding the use of GLP-1 drugs for alcohol addiction are mentioned?: Though effective in those with obesity or type 2 diabetes, the safety of GLP-1 drugs for those without these conditions requires more research, especially due to their weight-loss effects.
What were the main findings of the study regarding Ozempic and Wegovy's impact on alcohol use disorder?: Ozempic and Wegovy, GLP-1 drugs, showed a reduced likelihood of alcohol-related hospitalizations in a study of Swedish individuals with alcohol use disorder.
How many individuals participated in the Swedish study on GLP-1 drugs and alcohol-related hospitalizations?: The study, involving 228,000 individuals, indicated that those using semaglutide (Ozempic and Wegovy's active ingredient) had significantly fewer alcohol-related hospitalizations.

Jan 22, 04:12

Combined Healthy Waist and Exercise Key to Minimizing Cancer Risk

A study of 315,000 Britons reveals that maintaining a healthy waist circumference (below 88cm for women and 102cm for men) and engaging in 150-300 minutes of moderate or 75-150 minutes of vigorous weekly exercise is crucial for minimizing cancer risk; meeting only one guideline is insufficient.

Jan 22, 16:07

10 Foods to Reduce Colon Cancer Risk Amidst Rising Cases

A nutritionist urges increased consumption of 10 fiber-rich foods—oats, peas, prunes, raspberries, black beans, popcorn, almonds, chia seeds, avocado, and sweet potatoes—to combat a 52% rise in UK colon cancer cases among under-50s over 30 years, potentially due to low fiber diets.

Jan 21, 10:09

High Blood Pressure and Diabetes Prevalence and Prevention in the US

Approximately half of US adults have high blood pressure, and over 10% have diabetes, significantly increasing heart disease and stroke risks; early diagnosis and treatment, even without symptoms, are crucial, with lifestyle changes and medications offering effective management.

Jan 21, 10:09

Sedentary Behavior: Health Risks and Mitigation Strategies

Prolonged sitting reduces blood vessel elasticity and brain blood flow; regular movement breaks, active commuting, and strength training are crucial for mitigating health risks.